DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Zhou Y, Zong H, Han L. et al.
A novel bispecific antibody targeting CD3 and prolactin receptor (PRLR) against PRLR-expression breast cancer.
J Exp Clin Cancer Res 2020;
39 (01) 87
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.